Clinical trial
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
NCT06964464 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- Lead sponsor
- University of Rochester
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- August 17, 2025
- Completion date
- July 1, 2031
- Enrollment
- 2,000 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
beta-blocker therapy, cardiomyopathy, heart failure with reduced ejection fraction (hfref), implantable cardioverter defibrillator (icd), sudden cardiac death, ventricular arrhythmia